549-18-1-068-0001 Radiopharmaceutical Contract (VA-17-084897)

The purpose of this modification is to extend closing date to 09/18/2017 by 10:00 AM

Please note question will be accepted until Friday 09/14/2017 10:00 AM

It is being requested to award a firm-fixed price for a 5 year term, however, I am unable to located what the date terms are of this agreement. Can you please provide the effective date of the award and the end of date of the awarded contract? Oct 1 2017 to Sep 30 2022

Can a column be added to the table of Schedule of Supplies and Services to provide clarity of notes as to what is being bid? No

Line Item 1 Ga-67 Gallium Citrate UD: This item is typically billed and priced per mCi. Will you accept this as priced per mCi? No

Line Item 4 I-123 NaI 5mCi UD: Can you please provide further clarification as to what is being requested? Is this Liquid I-123, and 5mCi is being requested? Not Liquid; 5mCi capsule

Line Item 5 I-131 USP NaI Tx Hyperthyroidism Cap UD 1-30mCi: This item is typically billed and priced for the 1st mCi and then each additional mCi thereafter. Can this be provided as 1st mCi price and each additional thereafter? Yes

Line Item 6 I-131 USP NaI Dx Cap UD 1-6mCi: This item is typically billed and priced for the 1st mCi and then each additional mCi thereafter. Can this be provided as 1st mCi price and each additional thereafter?  Yes

Line Item 12 Pentetate Vial: Is a vial of In-111 Pentetate being requested, or a cold vial of Pentetate for use in Tc99m labeling? Cold vial

Line Item 24 Tc99m Pentetate UD: Is an aerosolized unit dose being requested or non-aerosolized? Aerosol listed when needed

Line Item 30 Tl-201 Thallous Chloride UD: This item is typically billed and priced per mCi. Will you accept this as priced per mCi? If not, please provide the size of unit dose requested. Yes

Line Item 45 I-131 USP NaI Dx Sol uCi UD: Can you please provide clarification as to what is being requested? Is this for a 0-100uCi Diagnostic Capsule? No: Liquid I-131 if needed

Line 46 In-111 WBC Blood Kit (Heparin): Heparin does require a separate prescription and must be requested by the facility. Can pricing be listed for the price of the blood collection kit, and then separate price of the Heparin? No

Line Item 47 Tc99m WBC Blood Kit (Heparin): Heparin does require a separate prescription and must be requested by the facility. Can pricing be listed for the price of the blood collection kit, and then separate price of the Heparin? No

Line Item 48 Sm-153 Lexidronam UD: This product pricing is set by the manufacturer on an annual basis and would unable to be priced for a firm fixed 5 year term. Can this be removed from the solicitation and handled as a modification upon award in the multi year? No

Line Item 49 Tc-99m NaTc04 uCi UD: Is the product being requested a flood source? Not a flood source

Line Item 52: Tc99m Succimer 1-6mCi UD: This product is not commercially available and not scheduled to be re-released from the manufactured until 2020. Can this be removed from the solicitation, or should N/A be placed in the pricing? List N/A if not able to provide

Extension to submit pricing for Monday, September 18? Will extend 09/18/2017 by 10:00 AM

10% RFC requested will this apply to MPI doses only (Sestamibi / Tetrofosmin) Not limited to MPI doses; This applies to all doses listed in SOW



Tiered pricing requested will this apply to MPI doses only-Applies to all doses listed in SOW

Firm-fixed price IDIQ does this apply to annual price increases only and are we allowed to present pass through language for proprietary products as well as extraordinary price increases or can we include mutually agreed upon price increases See 52.216-2 Economic Price Adjustment Standard Supplies

In what format, do we provide the Subcontracting Plan as specified by VAAR Subpart 819.7? Any format will be acceptable